baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

JP Morgan Put 120 PGR 17.01.2025/ DE000JL0EAT7 /

2024-06-25 10:50:10 AM	Chg.0.000	Bid12:35:17 PM	Ask12:35:17 PM	Underlying	Strike price	Expiration date	Option type
0.110EUR	0.00%	0.110 Bid Size: 1,000	0.260 Ask Size: 1,000	Progressive Corporat...	120.00 -	2025-01-17	Put

GlobeNewswire 2:00 PM AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial

GlobeNewswire 1:30 PM Zevra Therapeutics Expands Executive Leadership Team

GlobeNewswire 1:30 PM Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical D...

GlobeNewswire 1:00 PM Breckenridge Distillery Releases Award-Winning Collectors Art Series Collaboration With Abby Wren

GlobeNewswire 12:15 PM Fujifilm Launches 128-Slice Computed Tomography System, FCT iStream, with Vision Modeling Iterative ...

GlobeNewswire 12:05 PM Lulus Expands Footwear Offering By Welcoming Vans Into All-New “Lulus Loves” Capsule

GlobeNewswire 06-24 Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporat...

GlobeNewswire 06-24 NBME continues to be a Great Place To Work®

GlobeNewswire 06-24 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...

GlobeNewswire 06-24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...

GlobeNewswire 06-24 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...

GlobeNewswire 06-19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens

GlobeNewswire 06-18 Afamelanotide in fair-skinned Parkinson’s patients

GlobeNewswire 06-14 Progressive Reports May 2024 Results

GlobeNewswire 06-13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...

GlobeNewswire 06-12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...

GlobeNewswire 06-12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...

GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

GlobeNewswire 06-11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...

GlobeNewswire 06-11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...

GlobeNewswire 06-10 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...

GlobeNewswire 06-10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...

TeleTrader 06-09 EP updated results, EPP with 189 seats

TeleTrader 06-09 EPP's Weber claims party victory in EP election

GlobeNewswire 06-07 TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

JP Morgan Put 120 PGR 17.01.2025/ DE000JL0EAT7 /

If you wish to receive reply to your feedback, please provide your email address.